Replies to post #145870 on NanoViricides Inc. (NNVC)

[KMBJN]

This is laughable too:

For NV-COV-2:

The Company is currently working on a pre-IND application to the US Food and Drug Administration (FDA) to seek guidance for an IND.

For Herpes:

The IND-enabling Safety/Toxicology studies required for doing so have been completed and the Company was in the process of preparing an IND application for this drug candidate when the SRAS-CoV-2 virus struck, whereupon management pivoted its efforts to respond to the threat of what has now become the COVID-19 pandemic

Poor NNVC, so many drug candidates and nary an IND.